TruBridge(US:TBRG)2025-05-07 21:30Financial Data and Key Metrics Changes - Adjusted EBITDA for Q1 2025 nearly doubled to $18,200,000 compared to $10,000,000 in Q1 2024, with cash flow from operations increasing over $7,000,000 [5][20] - Revenue for Q1 2025 was $87,200,000, reflecting a year-over-year increase of 3.7%, and adjusted EBITDA margin improved to 20.9%, up 860 basis points from the prior year [24][28] - Net leverage ratio improved to 2.4 times in Q1 2025, down from 4.4 times a year ago [5][20] Business Line Data and Key Metrics Changes - Bookings for Q1 2025 totaled $22,000,000, down from $24,000,000 year-over-year, with financial health bookings at $13,000,000, a 50% sequential increase [6][7] - Patient care bookings were $9,000,000, a 60% sequential increase, with customer retention at 98% excluding Sentric [7][15] - Financial health represented 64% of total revenue at $56,100,000, a 5% increase year-over-year, while patient care revenue was $31,100,000, up 1.3% [26][27] Market Data and Key Metrics Changes - The company noted ongoing uncertainty related to future healthcare funding and potential impacts of tariffs on customer decision-making [10] - The shift to a SaaS model has affected the revenue mix, with a focus on recurring revenue rather than one-time fees [70] Company Strategy and Development Direction - The company is increasing investments in operational initiatives, including standardizing the global hiring process and enhancing customer service [12][14] - There is a focus on automation and leveraging AI to improve revenue cycle management [13][55] - The company aims to transition all bookings to an annual contract value (ACV) basis by 2026 for clearer revenue recognition [9][24] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding customer sentiment amid policy changes and potential impacts on hospital budgets [40] - The company is committed to improving forecasting processes and maintaining revenue expectations while increasing adjusted EBITDA guidance for the full year [30][31] Other Important Information - The company ended Q1 2025 with $10,100,000 in cash, compared to $4,100,000 a year ago, and net debt of $158,000,000 [29] - Operating expenses decreased to 45.3% of total revenue, down from 51.1% a year ago, due to cost optimization actions [28] Q&A Session Summary Question: Impact of policy changes on sales cycle - Management noted that while there is cautious sentiment regarding policy changes, they have not seen immediate impacts on sales conversations [39] Question: Potential net savings from staffing changes - Management expects mid-single-digit million savings from reducing duplicity in offshore and onshore staffing [43] Question: Meredith's plan of action and client retention - Focus is on improving client delight and retention through better training and infrastructure as the offshore operations scale up [50] Question: Non-subscription component of patient care bookings - Management acknowledged a shift to recurring revenue models and noted that new offerings are primarily based on the SaaS model [70] Question: Financial health client wins in the hospital market - Management confirmed that recent wins were in both the lower and upper ends of the 100 to 400 bed range, emphasizing the need for RCM services in this segment [74]